← Leaderboards
Sita Withers
Louisiana State Univ A&M Col Baton Rouge
$664,247
Attributed
$664,247
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $221.4K · FY2021–23$250K$187.5K$125K$62.5K$0
'21
'22
'23
Funding mix
By agency
NIH$664,247 · 1
By mechanism
P20$664,247 · 1
Top collaborators
No co-investigators on record.
Most similar at Louisiana State Univ A&M Col Baton Rouge
Same institution · by research overlap
- Seetharama D Jois$3,902,049
- Andrea Noel Johnston$936,721
- Elizabeth Martin$950,633
Others in their field
Other Emerging Leaders on “3-Dimensional”
- Karla Satchell · Northwestern University At Chicago$18,043,324
- Peter Myler · Seattle Children'S Hospital$17,499,932
- Hemali Phatnani · New York University School Of Medicine$12,981,994
- Stephen Wilson · La Jolla Institute For Immunology$11,742,477
- Tomasz Nowakowski · University Of California, San Francisco$11,499,053
- Siyuan Wang · Yale University$10,233,056
Research focus
3-DimensionalDrug Combinations3d PrintAnticancer ActivityDrug CandidateAntitumor EffectAnimal ModelBioprintingBreast Cancer ModelCancer Clinical TrialAnticancer ResearchAffectCanis FamiliarisCell LineCell PhysiologyCellsChemotherapyClientClinical TrialsCore FacilityCostDoctor Of PhilosophyDoseDrug Kinetics
Grant awards (3)
Strategic inhibition of EGFR-family signaling using novel peptidomimetic inhibitors of HER-2 for the treatment of osteosarcoma$221,416
P20 · FY2023 · GM · contact PI
Strategic inhibition of EGFR-family signaling using novel peptidomimetic inhibitors of HER-2 for the treatment of osteosarcoma$221,416
P20 · FY2022 · GM · contact PI
Strategic inhibition of EGFR-family signaling using novel peptidomimetic inhibitors of HER-2 for the treatment of osteosarcoma$221,415
P20 · FY2021 · GM · contact PI